Compass Therapeutics (CMPX) Net Cash Flow (2018 - 2026)
Compass Therapeutics recorded quarterly Net Cash Flow of $24.5 million in Q1 2026, up 257.52% quarter-over-quarter from -$15.6 million in Q4 2025, and up 1107.19% year-over-year from $2.0 million in Q1 2025.
Compass Therapeutics' Net Cash Flow history runs 9 years deep, the most recent figure standing at $24.5 million for Q1 2026.
- In Q1 2026, Net Cash Flow rose 1107.19% year-over-year to $24.5 million; the TTM figure through Mar 2026 stood at $14.1 million (down 18.73% YoY), while the FY2025 annual figure was -$12.8 million, down 166.68% from the prior year.
- Net Cash Flow came in at $24.5 million for Q1 2026 at Compass Therapeutics, up from -$15.6 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $24.5 million in Q1 2026 to a low of -$110.1 million in Q2 2022.
- A 5-year average of -$5.3 million and a median of -$4.3 million in 2024 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow tumbled 1206.85% in 2022 and jumped 1107.19% in 2026, its largest moves.
- Compass Therapeutics' Net Cash Flow stood at $18.5 million in 2022, then slumped by 133.57% to -$6.2 million in 2023, then jumped by 198.64% to $6.1 million in 2024, then tumbled by 354.65% to -$15.6 million in 2025, then jumped by 257.52% to $24.5 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $24.5 million, -$15.6 million, and $23.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Compass Therapeutics | 418.47 Mn | 223.78 Mn | - | 24.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.53 Mn |
| Mar 31, 2026 | 24.53 Mn |
| Dec 31, 2025 | -15.57 Mn |
| Dec 31, 2025 | -15.57 Mn |
| Sep 30, 2025 | 23.36 Mn |
| Sep 30, 2025 | 23.36 Mn |
| Jun 30, 2025 | -18.19 Mn |
| Jun 30, 2025 | -18.19 Mn |
| Mar 31, 2025 | -2.44 Mn |
| Mar 31, 2025 | -2.44 Mn |
| Dec 31, 2024 | 6.11 Mn |
| Dec 31, 2024 | 6.11 Mn |
| Sep 30, 2024 | 17.97 Mn |
| Sep 30, 2024 | 17.97 Mn |
| Jun 30, 2024 | -4.27 Mn |
| Jun 30, 2024 | -4.27 Mn |
| Mar 31, 2024 | -554,000.00 |
| Mar 31, 2024 | -554,000.00 |
| Dec 31, 2023 | -6.20 Mn |
| Dec 31, 2023 | -6.20 Mn |
| Sep 30, 2023 | 11.15 Mn |
| Sep 30, 2023 | 11.15 Mn |
| Jun 30, 2023 | -7.75 Mn |
| Jun 30, 2023 | -7.75 Mn |
| Mar 31, 2023 | -7.92 Mn |
| Mar 31, 2023 | -7.92 Mn |
| Dec 31, 2022 | 18.47 Mn |
| Dec 31, 2022 | 18.47 Mn |
| Sep 30, 2022 | -9.76 Mn |
| Sep 30, 2022 | -9.76 Mn |
| Jun 30, 2022 | -110.14 Mn |
| Jun 30, 2022 | -110.14 Mn |
| Mar 31, 2022 | -8.14 Mn |
| Mar 31, 2022 | -8.14 Mn |
| Dec 31, 2021 | 118.80 Mn |
| Dec 31, 2021 | 118.80 Mn |
| Sep 30, 2021 | -5.70 Mn |
| Sep 30, 2021 | -5.70 Mn |
| Jun 20, 2021 | -8.43 Mn |
| Jun 20, 2021 | -8.43 Mn |
| Mar 31, 2021 | -7.49 Mn |
| Mar 31, 2021 | -7.49 Mn |
| Sep 30, 2020 | 30.22 Mn |
| Sep 30, 2020 | 30.22 Mn |
| Jun 30, 2020 | 40.07 Mn |
| Jun 30, 2020 | 40.07 Mn |
| Mar 31, 2020 | -7.77 Mn |
| Mar 31, 2020 | -7.77 Mn |
| Dec 31, 2019 | -3,722.00 |
| Dec 31, 2019 | -3,722.00 |
| Sep 30, 2019 | -26.43 Mn |
| Sep 30, 2019 | -26.43 Mn |
| Jun 30, 2019 | -19.70 Mn |
| Jun 30, 2019 | -19.70 Mn |
| Dec 31, 2018 | 2,233.00 |
| Dec 31, 2018 | 2,233.00 |
| Jun 30, 2018 | 7,231.00 |
| Jun 30, 2018 | 7,231.00 |